SEC 13F Intelligence

Lion Point Capital, LP / KURA

Lion Point Capital, LP’s Kura Oncology Inc Position

Does Lion Point Capital, LP own Kura Oncology Inc (KURA)? Yes46.0K shares worth $373,980 (+2.24% of its 13F portfolio) as of Q1 2026.

Position Value
$373,980
Q1 2026
Shares
46.0K
% of Portfolio
+2.24%
Quarters Held
3
currently held

Position History KURA

Reported value by quarter
Q3 ’25: $407,100Q3 ’25Q4 ’25: $477,940Q4 ’25Q1 ’26: $373,980Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202646.0K$373,980+2.24%
Q4 202546.0K$477,940+2.47%
Q3 202546.0K$407,100+2.31%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of KURA.